Golasa Samadi Kochaksaraei
YOU?
Author Swipe
View article: Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study
Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study Open
CHB incidence decreased in Alberta, which is consistent with nationwide trends. Males and individuals aged 45-64 had higher CHB incidence and prevalence. CHB patients' lower survival rates emphasize the need to address barriers to guidelin…
View article: Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’
Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’ Open
Hepatitis B virus (HBV) infection affects >290 million people worldwide, including ∼250,000 Canadians, and it stands as a leading cause of end-stage liver disease and liver cancer. The World Health Assembly has set goals for HBV eliminatio…
View article: POS-291 ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE, MENSTRUAL REGULARITY AND REPRODUCTIVE LIFESPAN: A SYSTEMATIC REVIEW AND META-ANALYSIS
POS-291 ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE, MENSTRUAL REGULARITY AND REPRODUCTIVE LIFESPAN: A SYSTEMATIC REVIEW AND META-ANALYSIS Open
View article: Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients Open
We report high SVR rates in a real-world diverse cohort of HCV-infected patients treated with second-generation direct-acting antivirals. The results highlight the importance of conducting real-world analyses to elucidate clinical factors …